leukocyte antigen (hla) class ii allele frequencies in female patients with breast cancer: a case control study

Authors

ali-akbar amirzargar molecular immunology research center, tehran university of medical sciences

majid mahmoodi cancer research center, cancer institute, tehran university of medical sciences.

hedayat nahvi cancer research center, cancer institute, tehran university of medical sciences

mehdi mahmoodi molecular immunology research center, tehran university of medical sciences

abstract

background: the study aimed to examine the association between human leukocyte antigen (hla) class ii allele frequencies and breast cancer in iranian women. methods: a total of 100 patients with pathologically proven breast cancer who referred to cancer institute were randomly selected and compared with a group of age matched healthy blood donors (n = 80). hla class ii alleles were determined by amplification of dna followed by hla-typing using sequence-specific primer (ssp) for each allele. results: the frequency of hla-dqa1*0301 ( p =0.001, or=3.4) and hla-drb1*1303 ( p =0.02, or=2.3) among breast cancer patients was significantly higher than those in control group. hla-dqa1*0505 ( p =0.003, or=0.4), hla-drb1*1301 ( p =0.002, or=0.12) and hla-dqa1*0101 ( p =0.01, or=0.21) alleles showed negative association with breast cancer. conclusion: the findings suggest that hla-dqa1*0301 allele is mainly associated with increased risk of breast cancer in iranian female patients. hla-dqa1*0505 and hla-drb1*1301 alleles are suggested as protective genetic factors against breast cancer. the findings confirm that specific alleles of hla class ii influence breast cancer risk.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

HLA-B5 antigen in Iranian patients with Behcet’s disease: A case-control study

Background: The strong association of Behcet’s disease with HLA-B5 antigen has been observed in several ethnic groups from Middle East to Far East. Objective: To evaluate the frequency and association of HLA-B5 and also likelihood ratio of involvement in Behcet’s disease in a group of Iranian patients. Patients and Methods: HLA-B5 antigen typing was performed by serologic method in 56 patients ...

full text

Analysis of Human Leukocyte Antigen class II Gene Polymorphism in Iranian Patients with Papillon-Lefevre Syndrome: a Family Study

Background: Papillon-Lefevre syndrome (PLS) is a rare autosomal recessive disorder characterized by palmoplantar hyperkeratosis and early development of aggressive pe-riodontitis. Although cathepsin C (CTSC) gene mutations have been established in about 70-80% of PLS patients, it is assumed that the patients may have dysfunctioning of immune defense mechanisms. Objective: To assess the associat...

full text

"hla class ii allele and haplotype frequencies in iranian patients with acute myelogenous leukemia and control group "

previous studies have demonstrated some significant differences in hla allele frequencies in leukemic patients and normal subjects. we have analyzed hla class ii alleles and haplotypes in 60 iranian patients with acute myelogenous leukemia (aml) and 180 unrelated normal subjects. blood samples were collected after obtaining informed consents. from the patients and control dna extraction and hla...

full text

Human Leukocyte Antigen Class I and II Variants in Yemeni Patients with Chronic Renal Failure

Background: Human leukocyte antigens (HLAs) are found to be significant genetic factors concerning the susceptibility of an individual to certain diseases. Objective: To determine the association between variants of class I (A and B) and class II (DRB1) HLA alleles and chronic renal failure (CRF), compared with healthy controls, in Yemen. Methods: A case-control study in the Urology and Nephrol...

full text

My Resources

Save resource for easier access later


Journal title:
basic and clinical cancer research

جلد ۳، شماره ۱، صفحات ۳۶-۴۴

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023